[Federal Register Volume 62, Number 53 (Wednesday, March 19, 1997)]
[Notices]
[Page 13170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-6917]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 22, 1996, Knoll 
Pharmaceuticals, 30 North Jefferson Road, Whippany, New Jersey 07981, 
made application by renewal, which was received for processing February 
4, 1997, to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of hydromorphone (9150), a basic class of 
controlled substance in Schedule II.
    The firm plans to produce hydromorphone bulk product and finished 
dosage units of dilaudid for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 19, 1997.

    Dated February 26, 1997.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-6917 Filed 3-18-97; 8:45 am]
BILLING CODE 4410-09-M